Johnson & Johnson (JNJ)
Last Price$154.01.4%
Market Cap$392.3B
LTM EPS
$6.1
-55.2% YOY growth
NTM EPS
$9.6
+57.4% YOY growth
Current P/E
25.2x LTM
15.1x NTM
52w high P/E
27.4x LTM
17.3x NTM
52w low P/E
9.0x LTM
14.7x NTM
10Y avg P/E
45.7x LTM
50.6x NTM
JNJ Peter Lynch Chart
Crunching data... Almost there!
Best stock ideas on the market right now
With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.
Explore more intrinsic value tools hub for JNJ
Earnings growth model
Peter Lynch Fair Value
Earnings Power Value
Discount rate
Ben Graham Fair Value
Reverse DCF
Intrinsic Value
Margin of safety
DCF value calculator
coming soon...
Relative Value
coming soon...
Loved by
investors
worldwide
investors
worldwide
10K+
Investors
use our platform
#1
Top value investing hub
with all necessary tools
1K+
Experienced investors
in our community
4.9
Average rating across
all rating platforms
FAQ
What is Johnson & Johnson earnings per share (EPS)?
Johnson & Johnson earnings per share (EPS) for the twelve months ending Nov 15, 2024 was $6.1, a (55.2%) increase year-over-year.
What is Johnson & Johnson Price to Earnings (P/E) ratio?
As of Nov 15, 2024, Johnson & Johnson's P/E ratio is 25.2x. This is calculated by dividing the current share price of $154.0 by the Earnings per Share (EPS) for the trailing twelve months, which is $6.1. The P/E ratio indicates how much investors are willing to pay for each dollar of earnings.
Is Johnson & Johnson overvalued or undervalued?
Johnson & Johnson is currently considered overvalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $101.5, compared to a market price of around $154.0. This suggests a potential overvaluation of 34.1%.